# Cardiogenic Shock

## Background


#### **What's New**
The updated **American College of Cardiology (ACC)** and **American Heart Association (AHA)** guidelines for acute coronary syndromes (ACS) provide recommendations for the management of cardiogenic shock in ACS:

- **Emergency revascularization** of the culprit lesion by PCI or CABG is recommended regardless of time from symptom onset
- **Routine PCI** of a non-infarct-related artery should **NOT** be performed due to increased risk of renal failure and death
- **Short-term mechanical circulatory support** devices are suggested for hemodynamic stabilization as a bridge to surgery
- Based on the **DanGer-SHOCK trial**, a **microaxial intravascular flow pump** is now suggested for selected patients with STEMI and severe or refractory cardiogenic shock
- **Routine use** of intra-aortic balloon pump and venoarterial extracorporeal membrane oxygenation is **NOT recommended** due to lack of survival benefit


## Guidelines

### Key Sources
The following guidelines inform cardiogenic shock management:

1. **European Society of Intensive Care Medicine (ESICM 2025)**
2. **Society for Cardiovascular Angiography and Interventions (SCAI/NAEMSP/AHA/ACC/ACEP 2025)**
3. **Society of Critical Care Medicine (SCCM 2025)**
4. **European Society of Cardiology (ESC 2023, 2021)**
5. **Heart Failure Society of America (HFSA/AHA/ACC 2022)**
6. **Society for Cardiovascular Angiography and Interventions (SCAI/AHA/ACC 2022)**


## Clinical Findings

### ü©∫ Symptoms
- Dizziness
- Dyspnea
- Low urine output
- Orthopnea

### üìä Vital Signs
- Hypotension
- Tachycardia

### üìã Past Medical History
- Cardiac tamponade
- Cardiomyopathy
- Coronary artery disease
- Coronary artery dissection
- Heart failure (HF)
- Infective endocarditis
- Myocardial infarction
- Myocarditis
- Pulmonary embolism (PE)

---

## Major Clinical Studies

### üî¨ Recent Studies (2021-2025)

#### **2025 ‚Ä¢ Altshock-2** 
- **Finding:** In patients with HF-related cardiogenic shock suitable for heart replacement therapies, early intra-aortic balloon pump implantation was **not superior** to standard of care for survival or successful bridge to heart replacement therapies at 60 days
- **Citation:** Nuccia Morici et al. *J Am Coll Cardiol.* 2025 Apr 29
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/38723791/)**

#### **2025 ‚Ä¢ LACTEL**
- **Finding:** In adult patients with acute circulatory failure and arterial blood lactate levels ‚â• 3 mmol/L, CO‚ÇÇ-O2-derived algorithm-based treatment was **not superior** to standard clinical practice for lactate clearance > 10% within 2 hours
- **Citation:** Pierre-Gr√©goire Guinot et al. *Chest.* 2025 Apr
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/?term=LACTEL+circulatory+failure+lactate+clearance)**

#### **2024 ‚Ä¢ DanGer Shock (Secondary Analysis)**
- **Finding:** In patients with STEMI-induced cardiogenic shock, microaxial flow pump was **inferior** to standard care with respect to AKI
- **Citation:** Nanna Louise Junker Udesen et al. *JAMA Cardiol.* 2024 Oct 27:e244197
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/39466291/)**

#### **2024 ‚Ä¢ ECLS-SHOCK (1-Year Follow-up)**
- **Finding:** In patients with acute myocardial infarction complicated by cardiogenic shock, extracorporeal life support was **not superior** to standard medical care for all-cause mortality at 1 year
- **Citation:** Steffen Desch et al. *Eur Heart J.* 2024 Oct 14
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/39404063/)**

#### **2024 ‚Ä¢ DanGer Shock (Original Research)**
- **Finding:** In patients with STEMI-induced cardiogenic shock, microaxial flow pump was **superior** to standard care for death from any cause at day 180
- **Citation:** Jacob E M√∏ller et al. *N Engl J Med.* 2024 Apr 18
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/38587242/)**

#### **2023 ‚Ä¢ ECLS-SHOCK (Original Research)**
- **Finding:** In patients with acute myocardial infarction complicated by cardiogenic shock, extracorporeal life support was **not superior** to standard medical care for all-cause mortality at day 30
- **Citation:** Holger Thiele et al. *N Engl J Med.* 2023 Oct 5
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/37634277/)**

#### **2023 ‚Ä¢ EARLY-UNLOAD**
- **Finding:** In patients with cardiogenic shock undergoing venoarterial ECMO, early LV unloading was **not superior** to conventional approach for death from all causes at day 30
- **Citation:** Min Chul Kim et al. *Circulation.* 2023 Nov 14
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/37753706/)**

#### **2023 ‚Ä¢ DAMIS**
- **Finding:** In patients admitted to the ICU with circulatory shock, sublingual microcirculatory perfusion measurement was **not superior** to usual routine for death at day 30
- **Citation:** Raphael Romano Bruno et al. *Intensive Care Med.* 2023 Jun
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/?term=DAMIS+microcirculatory+perfusion+shock)**

#### **2021 ‚Ä¢ DOREMI**
- **Finding:** In adult patients with cardiogenic shock, milrinone was **not superior** to dobutamine for in-hospital death from any cause, resuscitated cardiac arrest, receipt of cardiac transplant or mechanical circulatory support, nonfatal myocardial infarction, TIA/stroke, or initiation of RRT
- **Citation:** Rebecca Mathew et al. *N Engl J Med.* 2021 Aug 5
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/34347950/)**

### üìö Landmark Historical Studies

#### **2018 ‚Ä¢ CULPRIT-SHOCK (1-Year Follow-up)**
- **Finding:** In patients with acute myocardial infarction complicated by cardiogenic shock, culprit lesion-only PCI was **not superior** to multivessel PCI for death at 1 year follow-up
- **Citation:** Holger Thiele et al. *N Engl J Med.* 2018 Nov 1
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/30145971/)**

#### **2017 ‚Ä¢ CULPRIT-SHOCK (Original Research)**
- **Finding:** In patients with STEMI/NSTEMI complicated by cardiogenic shock, culprit lesion-only PCI was **superior** to multivessel PCI for death or RRT at 30 days
- **Citation:** Thiele H et al. *N Engl J Med.* 2017 Dec 21
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/29083953/)**

#### **2012 ‚Ä¢ IABP-SHOCK II**
- **Finding:** In patients with cardiogenic shock complicating acute myocardial infarction expected to undergo early revascularization, IABP was **not superior** to control for death at 30 days
- **Citation:** Thiele H et al. *N Engl J Med.* 2012 Oct 4
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/22920912/)**

#### **1999 ‚Ä¢ SHOCK**
- **Finding:** In patients with shock due to LV failure complicating myocardial infarction, emergency revascularization was **not superior** to initial medical stabilization for death at 30 days
- **Citation:** Hochman JS et al. *N Engl J Med.* 1999 Aug 26
- **[PubMed Link](https://pubmed.ncbi.nlm.nih.gov/10451957/)**

---

## Diagnostic Investigations

### üîç Critical Care Ultrasound
As per SCCM 2025 guidelines,
- **Recommendation:** Consider obtaining critical care ultrasound in adult patients with cardiogenic shock to improve clinical outcomes
 (C)


### ü©∫ Pulmonary Artery Catheterization
As per ACC/AHA/HFSA 2022 guidelines,
- **Recommendation:** Consider placing a pulmonary artery line to define hemodynamic subsets and appropriate management strategies in patients presenting with cardiogenic shock
 (C)



## Medical Management

### üè• Setting of Care

#### **Cardiac ICU Admission**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** Admit patients with acute coronary syndrome and cardiogenic shock to a cardiac ICU to reduce cardiovascular events
 (B)


#### **Multidisciplinary Team**
As per ACC/AHA/HFSA 2022 guidelines,
- **Recommendation:** Consider managing patients with cardiogenic shock by a multidisciplinary team experienced in shock
 (C)


### üíä Pharmacological Management

#### **Inotropes**
As per ACC/AHA/HFSA 2022 guidelines,
- **Recommendation:** Administer IV inotropic support to maintain systemic perfusion and preserve end-organ performance in patients with cardiogenic shock
 (B)


#### **Vasopressors**
As per ESC 2021 guidelines,
- **Recommendation:** Consider administering a vasopressor, preferably **norepinephrine**, to increase BP and vital organ perfusion in patients with cardiogenic shock
 (C)


#### **Fluid Resuscitation**
As per ESICM 2025 guidelines,
- **Recommendation:** **DO NOT** use fluid resuscitation as the primary treatment for circulatory failure due to left-sided cardiogenic shock
 **Contraindicated**


#### **Fibrinolytic Therapy**
As per ESC 2023 guidelines,
- **Recommendation:** Consider administering fibrinolytic therapy in patients with STEMI presenting with cardiogenic shock if primary PCI is not available within 120 minutes of STEMI diagnosis and mechanical complications have been ruled out
 (C)



## Therapeutic Procedures

### ‚öôÔ∏è Mechanical Circulatory Support

#### **Microaxial Intravascular Flow Pump**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** Consider inserting a microaxial intravascular flow pump in **selected patients** with STEMI and severe or refractory cardiogenic shock to reduce mortality
 (C)
- **Updated Evidence:** DanGer Shock trial results

#### **Short-term Mechanical Circulatory Support**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** Consider using short-term mechanical circulatory support devices in patients with mechanical complications of acute coronary syndrome for hemodynamic stabilization as a bridge to surgery
 (C)


### üö´ **Intra-aortic Balloon Pump (IABP)**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** **DO NOT** use intra-aortic balloon pump or venoarterial ECMO routinely in patients with acute myocardial infarction and cardiogenic shock due to a **lack of survival benefit**
 (D) (Contraindicated)


#### **Exception for Mechanical Complications**
As per ESC 2023 guidelines,
- **Recommendation:** Consider performing intra-aortic balloon counterpulsation/pumping in patients with hemodynamic instability/cardiogenic shock due to acute coronary syndrome-related **mechanical complications**
 (C)

### ü©∏ Coronary Artery Revascularization

#### **Emergency Revascularization**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** Perform emergency revascularization of the culprit vessel by PCI or CABG in patients with acute coronary syndrome and cardiogenic shock or hemodynamic instability to improve survival, **irrespective of time from symptom onset**
 (B)

#### **Non-Infarct Related Artery PCI**
As per ACC/ACEP/AHA/SCAI 2025 guidelines,
- **Recommendation:** **DO NOT** perform routine PCI of a non-infarct-related artery at the time of primary PCI in patients with STEMI complicated by cardiogenic shock due to **higher risk of renal failure and death**
 (D) (Contraindicated)


#### **Emergency CABG**
As per ESC 2023 guidelines,
- **Recommendation:** Perform emergency CABG in patients with acute coronary syndrome-related cardiogenic shock if PCI of the infarct-related artery is unfeasible or unsuccessful
 (B)



## References

1. **Jos√© L D√≠az-G√≥mez, Sameer Sharif, Enyo Ablordeppey et al.** Society of Critical Care Medicine Guidelines on Adult Critical Care Ultrasonography: Focused Update 2024. *Crit Care Med.* 2025 Feb 1;53(2):e447-e458. [Open Access](https://journals.lww.com/ccmjournal/citation/2025/02000/society_of_critical_care_medicine_guidelines_on.34.aspx)

2. **Robert A Byrne, Xavier Rossello, J J Coughlan et al.** 2023 ESC Guidelines for the management of acute coronary syndromes. *Eur Heart J.* 2023 Oct 12;44(38):3720-3826. [Open Access](https://academic.oup.com/eurheartj/article/44/38/3720/7243102)

3. **Sunil V Rao, Michelle L O'Donoghue, Marc Ruel et al.** 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *Circulation.* 2025 Apr;151(13):e771-e862. [Open Access](https://www.ahajournals.com/doi/10.1161/CIR.0000000000001319)

4. **Armand Mekontso Dessap, Fayez AlShamsi, Alessandro Belletti et al.** European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: part 2-the volume of resuscitation fluids. *Intensive Care Med.* 2025 Mar;51(3):461-477. [Open Access](https://link.springer.com/article/10.1007/s00134-024-07677-z)

5. **Theresa A McDonagh, Marco Metra, Marianna Adamo et al.** 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. *Eur Heart J.* 2021 Sep 21;42(36):3599-3726. [Open Access](https://academic.oup.com/eurheartj/article/42/36/3599/6358045)

6. **Paul A Heidenreich, Biykem Bozkurt, David Aguilar et al.** 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *Circulation.* 2022 May 3;145(18):e895-e1032. [Open Access](https://www.ahajournals.com/doi/10.1161/CIR.0000000000001063)

7. **Jennifer S Lawton, Jacqueline E Tamis-Holland, Sripal Bangalore et al.** 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *Circulation.* 2022 Jan 18;145(3):e18-e114. [Open Access](https://www.ahajournals.com/doi/10.1161/CIR.0000000000001038)

8. **Holger Thiele, Ibrahim Akin, Marcus Sandri et al.** One-Year Outcomes after PCI Strategies in Cardiogenic Shock. *N Engl J Med.* 2018 Nov 1;379(18):1699-1710. [Open Access](https://www.nejm.org/doi/10.1056/NEJMoa1808788)

9. **Holger Thiele, Uwe Zeymer, Franz-Josef Neumann et al.** Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. *Lancet.* 2013 Nov 16;382(9905):1638-45. [Open Access](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61783-3/fulltext)

10. **Rebecca Mathew, Pietro Di Santo, Richard G Jung et al.** Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. *N Engl J Med.* 2021 Aug 5;385(6):516-525. [Open Access](https://www.nejm.org/doi/10.1056/NEJMoa2026845)

11. **Min Chul Kim, Yongwhan Lim, Seung Hun Lee et al.** Early left ventricular unloading after extracorporeal membrane oxygenation: rationale and design of EARLY-UNLOAD trial. *ESC Heart Fail.* 2023 Aug;10(4):2672-2679. [Open Access](https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14451)

12. **Min Chul Kim, Yongwhan Lim, Seung Hun Lee et al.** Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial. *Circulation.* 2023 Nov 14;148(20):1570-1581. [Open Access](https://www.ahajournals.com/doi/10.1161/CIRCULATIONAHA.123.066285)

13. **Ovidiu Chioncel, John Parissis, Alexandre Mebazaa et al.** Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology. *Eur J Heart Fail.* 2020 Aug;22(8):1315-1341. [Open Access](https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1922)

14. **Behnam N Tehrani, Alexander G Truesdell, Mitchell A Psotka et al.** A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. *JACC Heart Fail.* 2020 Nov;8(11):879-891. [Open Access](https://www.jacc.org/doi/10.1016/j.jchf.2020.09.005)

15. **Corstiaan A den Uil, Wim K Lagrand, Suzanne D A Valk et al.** Management of cardiogenic shock: focus on tissue perfusion. *Curr Probl Cardiol.* 2009 Aug;34(8):330-49. [Open Access](https://www.sciencedirect.com/science/article/pii/S0146280609000424)

16. **M G Lindholm, S Boesgaard, C Torp-Pedersen et al.** Diabetes mellitus and cardiogenic shock in acute myocardial infarction. *Eur J Heart Fail.* 2005 Aug;7(5):834-9. [Open Access](https://onlinelibrary.wiley.com/doi/10.1016/j.ejheart.2004.10.007)

17. **Matthieu Schmidt, Aidan Burrell, Lloyd Roberts et al.** Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. *Eur Heart J.* 2015 Sep 1;36(33):2246-56. [Open Access](https://academic.oup.com/eurheartj/article/36/33/2246/2293277)

18. **Jacob E M√∏ller, Thomas Engstr√∏m, Lisette O Jensen et al.** Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. *N Engl J Med.* 2024 Apr 18;390(15):1382-1393. [Open Access](https://www.nejm.org/doi/10.1056/NEJMoa2312572)

19. **Steffen Desch, Uwe Zeymer, Ibrahim Akin et al.** Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial. *Eur Heart J.* 2024 Oct 14;45(39):4200-4203. [Open Access](https://academic.oup.com/eurheartj/article/45/39/4200/7799542)

20. **Holger Thiele, Uwe Zeymer, Ibrahim Akin et al.** Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. *N Engl J Med.* 2023 Oct 5;389(14):1286-1297. [Open Access](https://www.nejm.org/doi/10.1056/NEJMoa2307227)

21. **Nanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager et al.** Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical Trial. *JAMA Cardiol.* 2024 Oct 27:e244197. [Open Access](https://jamanetwork.com/journals/jamacardiology/fullarticle/2824997)

22. **Elric Zweck, Christian Hassager, Rasmus P Beske et al.** Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock - a Secondary Analysis of the DanGer Shock Trial. *Circulation.* 2024 Dec 17;150(25):1990-2003. [Open Access](https://www.ahajournals.com/doi/10.1161/CIRCULATIONAHA.124.070959)

23. **Nuccia Morici, Alice Sacco, Simone Frea et al.** Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial. *J Am Coll Cardiol.* 2025 Apr 29;85(16):1587-1597. [Open Access](https://www.jacc.org/doi/10.1016/j.jacc.2025.02.003)
